Brief: Spyre Therapeutics Appoints Mark Mckenna To Its Board Of Directors
05/02/2024 12:49
Feb 5 (Reuters) - Spyre Therapeutics Inc SYRE.O :
* SPYRE THERAPEUTICS APPOINTS ACCOMPLISHED BIOPHARMA AND IBD
LEADER MARK C. MCKENNA, FORMER CHAIRMAN, PRESIDENT, AND CEO OF
PROMETHEUS BIOSCIENCES, TO ITS BOARD OF DIRECTORS
Source text for Eikon: ID:nPnbbw6wza
Further company coverage: SYRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spyre Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
U.S. STOCKS ON THE MOVE-MYR Group, Spyre Therapeutics, AMD
Spyre Therapeutics slips on $350 mln share sale
Brief: Spyre Therapeutics Announces Pricing Of $350.0 Million Public Offering Of Common Stock